deltatrials
Recruiting PHASE2 INTERVENTIONAL 1-arm NCT02476786

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Endocrine Treatment Alone as Primary Treatment for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Sponsor: Genomic Health®, Inc.

Conditions Breast Cancer Breast Neoplasms Cancer of Breast Cancer of the Breast
Interventions Anastrozole Archived tissue collection Exemestane FACT-B Fulvestrant Goserelin Tamoxifen
Updated 19 times since 2017 Last updated: Jul 23, 2025 Started: Jan 17, 2017 Primary completion: Jan 31, 2027 Completion: Jul 31, 2032
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Breast Cancer and Breast Neoplasms, this trial is actively recruiting participants. The trial is conducted by Genomic Health®, Inc. and has accumulated 19 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Apr 2019 · 8 months · monthly snapshot~Apr 2019 – ~Feb 2020 · 10 months · monthly snapshot~Feb 2020 – ~Jul 2020 · 5 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Mar 2022 · 12 months · monthly snapshot~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshot~Sep 2022 – ~Jan 2023 · 4 months · monthly snapshot~Jan 2023 – ~Jan 2024 · 12 months · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

19 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting PHASE2

  2. Aug 2025 — Sep 2025 [monthly]

    Recruiting PHASE2

  3. Sep 2024 — Aug 2025 [monthly]

    Recruiting PHASE2

  4. Aug 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  5. Jul 2024 — Aug 2024 [monthly]

    Recruiting PHASE2

▶ Show 14 earlier versions

  1. Jan 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

  2. Jan 2023 — Jan 2024 [monthly]

    Recruiting PHASE2

  3. Sep 2022 — Jan 2023 [monthly]

    Recruiting PHASE2

  4. Mar 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  5. Mar 2021 — Mar 2022 [monthly]

    Recruiting PHASE2

  6. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE2

  7. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  8. Feb 2020 — Jul 2020 [monthly]

    Recruiting PHASE2

  9. Apr 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

  10. Aug 2018 — Apr 2019 [monthly]

    Recruiting PHASE2

  11. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE2

  12. Aug 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  13. Feb 2017 — Aug 2017 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  14. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Genomic Health®, Inc.
  • Washington University School of Medicine
Data source: Washington University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations